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Background: Dyspepsia is common among end-stage renal disease (ESRD) patients and its association with
delayed gastric emptying is not well established. We assessed the association of dyspepsia with gastric emptying
time in ESRD patients undergoing hemodialysis (HD).
Methods: Dyspepsia was assessed through the Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ). PADYQ’s
scores ≥ 6 classified participants as dyspeptic. The octanoic acid breath test using 13carbon was employed to assess
the gastric emptying time. Based on the test, time in minutes to metabolize the first half of the 13carbon in the test
meal (t1/2) was calculated. Association of dyspepsia with gastric emptying time was tested by the correlation
between PADYQ scores and t1/2, and also by comparing t1/2 between dyspeptics and non-dyspeptics.
Results: There were 34 (68.0%) dyspeptic patients. Dyspepsia score was positively correlated with t1/2 (r = 0.366;
p = 0.009). Dyspeptics had longer t1/2 compared to non-dyspeptics, respectively, 238.0 ± 92.9 versus 185.5 ± 45.5
minutes (p = 0.042).
Conclusions: Delayed gastric emptying was associated with dyspepsia. Prokinetic medications could have a role in
preventing or relieving dyspeptic symptoms among HD patients. Future research in larger samples is necessary to
confirm this association.
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The most common non-renal complaints in end-stage
renal disease (ESRD) patients are gastrointestinal symp-
toms such as heartburn, constipation, diarrhea and dys-
pepsia [1]. Dyspepsia is highly prevalent and characterized
by upper abdominal pain, nausea, vomiting, upper abdom-
inal bloating, and early satiety [2]. The prevalence of dys-
pepsia among HD patients varies between 48% and 70%
[3,4]. In the general population, dyspepsia has been shown
to impair quality of life [5]. Nevertheless, dyspeptic symp-
toms are not widely investigated among patients treated
by HD, as is usually the case in relation to cardiovascular
disease, osteodystrophy and nutritional status.
Dyspepsia may have organic and functional causes.
Like in the general population, functional dyspepsia is* Correspondence: prsantos@fortalnet.com.br
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distribution, and reproduction in any mediumthe most frequent among ESRD patients [6]. There are
reports of the possible role of gastric emptying delay as
a cause of dyspeptic symptoms in HD patients [3]. Gas-
troparesis is better recognized in diabetics. However, its
presence is also high in all-cause ESRD, varying between
36% to 62% among patients undergoing chronic HD
[3,7]. In these patients, delay in gastric emptying can be
related to malnutrition and hormonal and electrolytic
disturbances [8].
Dyspepsia can be easily evaluated through a questionnaire
about characteristic symptoms, although gastric empty-
ing time is not so easily assessed. The tools available to
estimate gastric emptying time are: technetium-99 m
scintigraphy (gold –pattern) [9]; time of appearance of
acetaminophen in blood after its ingestion [10]; imaging
studies using 3D ultrasonography and nuclear resonance
[11,12]; the smart pill (which seems to be a practical and
promising method) [13]; and octanoic acid breath testntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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standard technetium-99 m scintigraphy) [14].
In our study, we looked for an association between
dyspepsia and gastric emptying time in an experiment




Fifty ESRD patients were randomly selected from a total
of 225 patients undergoing HD in a single dialysis center
during October 2011, after excluding patients: (i) under
18 years old, (ii) with less than three months of mainten-
ance HD, (iii) with a history of abdominal surgery,
chronic obstructive lung disease or chronic hepatic dis-
ease, (iv) with gallstone by ultrasonography, and (v) with
endoscopy showing gastric ulcer, inflammation or struc-
tural alterations. Written informed consent was obtained
from all participants, and the study was approved by the
ethics committee of Federal University of Ceará.
Dyspepsia assessment
Dyspepsia was assessed using a validated Brazilian ver-
sion of a standardized questionnaire named the Porto
Alegre Dyspeptic Symptoms Questionnaire (PADYQ)
[2]. PADYQ allows quantitative analysis of symptoms of
dyspepsia not related to ulcer and in accordance with
the Rome I Consensus. It contains 11 questions about
the presence, frequency, duration and intensity of five
symptoms: upper abdominal pain, nausea, vomiting,
upper abdominal bloating, and early satiety. Subjects
were asked about the occurrence of these symptoms in
the previous 30 days. Maximum score of 44. A score ≥ 6
classified the subject as dyspeptic. The assessment was
administered by a single interviewer who was not a
member of the regular dialysis unit team.
Gastric emptying time assessment
Patients were instructed to avoid smoking and eating
food rich in C-4 plants, like corn (including baked goods
made with cornmeal) and pineapples, in the week before
the study. After a minimum of 10 hours of fasting and
immediately before the intermediate weekly session of
HD, all patients completed the octanoic acid breath test
was performed [14]. They were instructed to eat a solid
meal, consisting of a scrambled egg with the yolk labeled
with 100 μg of 13carbon octanoic acid. After homogeniz-
ing the yolk, the egg white was added, beaten and baked.
It was ingested with 60 g of white bread and 5 g of mar-
garine during 1 to 5 min and followed immediately by
150 mL of water.
To collect the breath samples, the patients exhaled
into closed aluminized plastic bags, before the test meal
(baseline), and then at 15-minute intervals during2 hours and then every 30 min for a further 2 hours.
The patients were advised to remain seated and refrain
from physical activity during the test [15].
The gastric emptying rate was defined by half-emptying
time (t1/2). T1/2 is the time in minutes for the first half of
the 13carbon dose in the test meal to be metabolized. The
t1/2 was calculated as described by Ghoos et al. [14]. Ac-
cordingly, t1/2 of more than 200 minutes identified gastric
emptying delay. Both the apparatus (IRIS II-13C-Breath
Test System) and substrate (13C-octanoic acid) used here
were supplied by Wagner Analysen Technik (Bremen,
Germany).
Patient data
The demographic data, length of time on dialysis, num-
ber of current medications, use of antacids and under-
lying etiology of ESRD were obtained from the renal
unit medical records. The underlying renal disease was
classified according to clinical criteria only. Body mass
index was calculated as Kg/m2. All participants com-
pleted laboratory tests for serum creatinine, albumin,
hemoglobin, calcium and phosphorus were performed.
The dose of dialysis delivered was evaluated using a
second-generation Kt/V equation by Daugirdas [16].
Statistical analyses
Data are mean ± SD or percentage. Comparisons were
performed by the Student-t and Mann-Whitney tests for
continuous variables, respectively with or without normal
distribution. Comparisons of frequencies were carried out
by the Fisher test. The Pearson test, adjusted to traditional
HD sample confounders (age, gender, diabetes, time on
dialysis, hemoglobin, albumin and Kt/V), was used to test
correlation between continuous variables. Statistical sig-
nificance was considered to be a P value of < 0.05. All the
statistical analyses were performed using the SPSS version
13.0 program package.
Results
Our sample consisted of 36 (72%) men and 14 (28%)
women, with mean age of 42.5 ± 16.6 years, undergoing
maintenance HD for 32.4 ± 34.7 months. Primary renal
diseases were glomerulonephritis in 17 (34%), hyperten-
sive nephrosclerosis in 12 (24%), diabetes in 12 (24%),
obstructive nephropathy in 6 (12%) and undetermined in
3 (6%). Patients had mean body mass index within normal
range (22.4 ± 4.1).
The laboratory results were hemoglobin of 10.1 ± 2.0 g/dl,
albumin of 4.1 ± 0.7 g/dl, calcium of 9.2 ± 1.0 mg/dl,
phosphorus of 4.7 ± 1.4 mg/dl and Kt/V of 1.4 ± 0.2.
Thirty-four (68%) patients were dyspeptic (PADYQ
score ≥ 6). Mean PADYQ scores were 2.5 ± 2.3 and 16.8 ±
6.4 among non-dyspeptics and dyspeptics, respectively.







Male 23 (67.6) 13 (81.3)
Female 11 (32.4) 3 (18.8)
Age 39.6 ± 16.5 48.6 ± 15.5 0.075
Etiology of ESRD
Glomerulonephritis 14 (41.2) 3 (18.8) 0.200
Hypertension 9 (26.5) 3 (18.8) 0.728
Diabetes 6 (17.6) 6 (37.5) 0.163
Obstructive uropathy 3 (18.8) 3 (18.8) 0.370
Undetermined 2 (5.9) 1 (6.3) 1.000
Months on dialysis 31.9 ± 30.7 33.5 ± 43.1 0.877
Using antacids 21 (61,7) 4 (25,0) 0.173
Number of
medications
3.3 ± 0.9 3.6 ± 0.8 0.972
Body mass index (kg/m2) 22.3 ± 4,5 22.6 ± 3.3 0.897
Creatinine (mg/dl) 8.5 ± 2.9 8.1 ± 2.4 0.611
Hemoglobin (g/dl) 9.8 ± 2.1 10.9 ± 1.5 0.075
Albumin (g/dl) 4.1 ± 0.7 4.2 ± 0.8 0.571
Calcium (mg/dl) 9.1 ± 1.0 9.5 ± 1.0 0.155
Phosphorus (mg/dl) 4.9 ± 1.5 4.2 ± 1.1 0.115
Kt/V 1.4 ± 0.2 1.4 ± 0.2 0.965
Data are means ± SD, or percentages (in parentheses).
ESRD, End-stage renal disease.
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and laboratory variables between patients with and with-
out dyspepsia (Table 1).
The breath test was well tolerated by all participants
and did not cause any adverse reactions.Figure 1 Comparison of t1/2 between dyspeptics and non-dyspepticsGastric emptying time estimated by t1/2 was different
between dyspeptics and non-dyspeptics, respectively
238.0 ± 92.9 vs. 185.5 ± 45.5 minutes (p = 0.042) (Figure 1).
According to the cut-off point of 200 minutes to classify
gastric emptying delay, the mean t1/2 indicated gastric
emptying delay among dyspeptics but not among non-
dyspeptics. Additionally, the t1/2 was positively correlated
with dyspepsia score (r = 0.366; p = 0.009) (Figure 2).
Discussion
Our results confirmed the hypothesis that gastric empty-
ing delay is associated with dyspepsia among ESRD pa-
tients on HD. First, we found longer gastric emptying
time in dyspeptics compared to non-dyspeptics. Indeed,
among dyspeptics, mean gastric emptying time was above
the cut-off of 200 minutes, which classifies gastric empty-
ing delay [14]. On the other hand, mean gastric emptying
time was below 200 minutes in non-dyspeptics. Second,
there was a positive correlation between gastric emptying
time and dyspepsia score (higher score associated with
more dyspeptic symptoms).
Due to its high prevalence and potential clinical im-
portance, practitioners should pay attention to dyspepsia
among the various ESRD patient symptoms. The preva-
lence of 68% in our study is within the range found in
the literature, from 48% to 70% [3,4]. Dyspeptic symp-
toms can negatively affect quality of life and psycho-
logical well-being in the general population as well as in
ESRD patients [5,17]. Awareness of the most common
mechanisms involved in dyspepsia generation is crucial
for successful management of dyspepsia. In theory, im-
provement of dyspepsia could ameliorate patients’ qual-
ity of life.
Unfortunately, gastric emptying delay, a suggested mech-
anism provoking dyspepsia, is difficult to assess in daily.
Figure 2 Correlation between t1/2 and dyspepsia scores.
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suitable for larger samples due to the cost and need to
spend extensive time for each evaluation.
Although we found a significant positive and linear
correlation between t1/2 and dyspepsia score, we cannot
ignore the overlap of gastric emptying time between the
groups with and without dyspepsia (Figure 1). This is ex-
pected when studying dyspepsia, which is known to have
multifactorial causes. Further studies are necessary to
confirm gastric emptying delay as a main cause of dys-
pepsia among patients on HD and to formulate recom-
mendations for appropriate treatment.
Even with a small size, our sample is larger compared
to prior studies [18-20]. Indeed, to the best of our know-
ledge this study involves the first clinical sample of Brazilian
HD patients submitted to an evaluation of gastric empty-
ing rate using the 13carbon octanoic acid breath test. We
are aware of limitations. First, the PAQYQ was validated
in a group of Brazilian patients with nonulcer dyspepsia
and healthy volunteers, but not specifically among ESRD
patients. Second, it would be better to study diabetics and
non-diabetics separately because diabetics are likely to
present more gastroparesis than non-diabetics. However,
our resources limited us to 50 experiments. Thus, random
selection was used and generated a typical HD sample
from underdeveloped regions with 25% diabetics. Third,
only routine laboratory variables were evaluated. If we
could test other laboratory variables such as gastrointes-
tinal peptide and cytokines levels, it would help to eluci-
date the mechanisms involved in the relationship of
dyspepsia, gastric emptying and renal failure.As a preliminary study, we believe the clinical implica-
tions that must be highlighted are that practitioners
should routinely search for symptoms of dyspepsia in HD
patients. Dyspepsia is highly prevalent and easy to assess.
Second, the treatment of dyspepsia could improve quality
of life in HD patients. Third, the use of prokinetics in
cases of proven functional dyspepsia, when other treat-
ments of dyspeptic symptoms are not successful, will de-
pend on further studies confirming the role of gastric
emptying time as an independent cause of dyspepsia.
Conclusions
Functional dyspepsia is very prevalent and is associated
with gastric emptying delay. We assessed gastric emptying
time by the octanoic acid breath test in a sample of ESRD
on HD. Our findings raise the question about the role of
prokinetics when the usual treatment of dyspeptic symp-
toms is not successful in proven functional dyspepsia
cases. Future research is needed with larger samples, using
a more workable method of measuring gastric emptying
time.
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